Evidence map›Paper›PMID 28402286›Full record

ArticlePhysics in medicine and biology2017

Longitudinal optical monitoring of blood flow in breast tumors during neoadjuvant chemotherapy.

J M Cochran, S H Chung, A Leproux, W B Baker, D R Busch, A M DeMichele, J Tchou, B J Tromberg, A G Yodh

Abstract read
In one paragraph

Article in Physics in medicine and biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

J M CochranDepartment of Physics and Astronomy, University of Pennsylvania, 209 S 33rd St, Philadelphia, PA 19104, United States of America.
S H ChungDepartment of Physics and Astronomy, University of Pennsylvania, 209 S 33rd St, Philadelphia, PA 19104, United States of America.
A LeprouxBeckman Laser Institute, University of California Irvine, Irvine, CA 92612, United States of America.
W B BakerDepartment of Physics and Astronomy, University of Pennsylvania, 209 S 33rd St, Philadelphia, PA 19104, United States of America.
D R BuschDepartment of Physics and Astronomy, University of Pennsylvania, 209 S 33rd St, Philadelphia, PA 19104, United States of America.
A M DeMicheleDepartment of Medicine (Hematology/Oncology), Hospital of the University of Pennsylvania, Philadelphia, PA 19104, United States of America.
J TchouDepartment of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, United States of America.
B J TrombergBeckman Laser Institute, University of California Irvine, Irvine, CA 92612, United States of America.
A G YodhDepartment of Physics and Astronomy, University of Pennsylvania, 209 S 33rd St, Philadelphia, PA 19104, United States of America.

Funding

ARRA - ADOPT New Technologies for RDC/CDMSU01CA080098 · NCI · AMERICAN COLLEGE OF RADIOLOGY · PI SCHNALL, MITCHELL D. · 1999 to 2011
$182.7M
BIOSTATISTICS DATA MANAGEMENT CENTER FOR ACROINU01CA079778 · NCI · BROWN UNIVERSITY · PI GATSONIS, CONSTANTINE A. · 1999 to 2011
$48.6M
Training in Molecular Therapeutics for Pediatric CardiologyT32HL007915 · NHLBI · CHILDREN'S HOSP OF PHILADELPHIA · PI Robert J Levy, JOSEPH W ROSSANO · 1999 to 2026
$13.4M
Training and DisseminationP41EB015893 · NIBIB · UNIVERSITY OF PENNSYLVANIA · PI REDDY, RAVINDER · 2012 to 2019
$11.3M
Virtual Photonocs TechnologiesP41EB015890 · NIBIB · UNIVERSITY OF CALIFORNIA-IRVINE · PI DURKIN, ANTHONY · 2012 to 2017
$7.0M
Diffuse Optics for Acute Stroke ManagementR01NS060653 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI YODH, ARJUN G. · 2008 to 2018
$5.5M
Developing DOSI Technology for Monitoring Response To Breast Cancer ChemotherapyR01CA142989 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI DURKIN, ANTHONY J · 2010 to 2017
$4.1M
Multi-Spectral Parallel-Plate Diffuse Optical Breast TomographyR01EB002109 · NIBIB · UNIVERSITY OF PENNSYLVANIA · PI YODH, ARJUN G. · 2003 to 2012
$3.9M
Detection of Cerebral Ischemia With a Noninvasive Neurometabolic Optical MonitorR01NS082309 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI KOFKE, W ANDREW · 2014 to 2018
$2.9M
Augmented Physiologic Monitoring to Predict Brain Injury in Infants with CHDR01NS072338 · NINDS · CHILDREN'S HOSP OF PHILADELPHIA · PI LICHT, DANIEL JACQUES · 2011 to 2015
$1.7M
Monitoring Breast Cancer Chemotherapeutic Response Using DOSI, MRI and BiomarkersU54CA136400 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI TROMBERG, BRUCE J. · 2009 to 2011
$1.3M
NCI NIH HHS R01 CA142989NCI NIH HHS U01 CA079778NCI NIH HHS U01 CA080098NCI NIH HHS U54 CA136400NHLBI NIH HHS T32 HL007915NIBIB NIH HHS P41 EB015890NIBIB NIH HHS P41 EB015893NIBIB NIH HHS R01 EB002109NINDS NIH HHS R01 NS060653NINDS NIH HHS R01 NS072338NINDS NIH HHS R01 NS082309
6 · The paper itself

Abstract

We measure tissue blood flow markers in breast tumors during neoadjuvant chemotherapy and investigate their correlation to pathologic complete response in a pilot longitudinal patient study (n  =  4). Tumor blood flow is quantified optically by diffuse correlation spectroscopy (DCS), and tissue optical properties, blood oxygen saturation, and total hemoglobin concentration are derived from concurrent diffuse optical spectroscopic imaging (DOSI). The study represents the first longitudinal DCS measurement of neoadjuvant chemotherapy in humans over the entire course of treatment; it therefore offers a first correlation between DCS flow indices and pathologic complete response. The use of absolute optical properties measured by DOSI facilitates significant improvement of DCS blood flow calculation, which typically assumes optical properties based on literature values. Additionally, the combination of the DCS blood flow index and the tissue oxygen saturation from DOSI permits investigation of tissue oxygen metabolism. Pilot results from four patients suggest that lower blood flow in the lesion-bearing breast is correlated with pathologic complete response. Both absolute lesion blood flow and lesion flow relative to the contralateral breast exhibit potential for characterization of pathological response. This initial demonstration of the combined optical approach for chemotherapy monitoring provides incentive for more comprehensive studies in the future and can help power those investigations.

Indexed as

Neoadjuvant TherapyOptical ImagingAdultAgedBreast NeoplasmsFemaleHumansLongitudinal StudiesMiddle AgedOxygenSpectrum AnalysisOxygen

Identifiers

PMID28402286
PMCPMC5584633

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.